Related Experiment Video
Updated: Aug 11, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Clozapine associated dilated cardiomyopathy
1Cardiology Department, Kingston Hospital NHS Trust. marktanner@lycos.co.uk
Insights
Clozapine, an antipsychotic, can rarely cause serious heart problems like dilated cardiomyopathy, even years after starting treatment. Persistent sinus tachycardia may be the only early sign, necessitating vigilant cardiac monitoring in patients on clozapine.
Area of Science:
- Cardiology
- Psychiatry
- Pharmacology
Background:
- Clozapine is an essential atypical antipsychotic medication used for treatment-resistant schizophrenia.
- While effective, clozapine carries known risks, including agranulocytosis and metabolic syndrome.
- Cardiac complications, though rare, are a serious concern associated with clozapine therapy.
Observation:
- A 31-year-old male patient on long-term clozapine therapy (6 years) presented with persistent sinus tachycardia.
- Electrocardiogram revealed sinus tachycardia, left ventricular hypertrophy, and a prolonged QTc interval.
- Echocardiography indicated the presence of dilated cardiomyopathy.
Findings:
- The patient's presentation suggests a potential association between long-term clozapine use and the development of dilated cardiomyopathy.
- Sinus tachycardia, often overlooked, can be a critical early indicator of clozapine-induced cardiac toxicity.
- Cardiac adverse events from clozapine can manifest insidiously, potentially years after treatment initiation.
Implications:
- Clinicians must maintain a high index of suspicion for cardiac complications in all patients receiving clozapine, regardless of treatment duration.
- Routine cardiac monitoring, including ECG and echocardiography, should be considered for patients on long-term clozapine.
- Informing patients about potential cardiac symptoms and ensuring prompt medical evaluation are crucial for early detection and management of clozapine-related cardiotoxicity.
Abstract:
A 31-year-old white man was referred for investigation of a persistent sinus tachycardia. His only significant past medical history was of chronic schizophrenia for which he had been taking clozapine for six years. An electrocardiogram demonstrated sinus tachycardia, voltage criteria for left ventricular hypertrophy, and a prolonged QTc. Echocardiographic findings were consistent with a dilated cardiomyopathy. Serious cardiac complications of clozapine use are rare but have been reported previously. It is important to note that sinus tachycardia may be the only obvious clinical sign, and that complications can manifest months or even years (as in this case) after starting the drug. Patients on clozapine should be informed of potential cardiac symptoms and doctors should maintain a high degree of clinical suspicion throughout the duration of treatment.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

